Zealand Eyes Opportunities In Burgeoning Obesity Market
Boehringer-Partnered Drug Moving Into Phase III Soon
Executive Summary
Given the renewed interest in the commercial potential of obesity therapies, Zealand is heralding the potential of its treatments for the overweight.